Literature DB >> 24397487

EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.

Zhuo Ma1, Sukalyani Banik, Harshita Rane, Vanessa T Mora, Seham M Rabadi, Christopher R Doyle, David G Thanassi, Chandra Shekhar Bakshi, Meenakshi Malik.   

Abstract

Francisella tularensis is a category A biodefence agent that causes a fatal human disease known as tularaemia. The pathogenicity of F. tularensis depends on its ability to persist inside host immune cells primarily by resisting an attack from host-generated reactive oxygen and nitrogen species (ROS/RNS). Based on the ability of F. tularensis to resist high ROS/RNS levels, we have hypothesized that additional unknown factors act in conjunction with known antioxidant defences to render ROS resistance. By screening a transposon insertion library of F. tularensis LVS in the presence of hydrogen peroxide, we have identified an oxidant-sensitive mutant in putative EmrA1 (FTL_0687) secretion protein. The results demonstrate that the emrA1 mutant is highly sensitive to oxidants and several antimicrobial agents, and exhibits diminished intramacrophage growth that can be restored to wild-type F. tularensis LVS levels by either transcomplementation, inhibition of ROS generation or infection in NADPH oxidase deficient (gp91Phox(-/-)) macrophages. The emrA1 mutant is attenuated for virulence, which is restored by infection in gp91Phox(-/-) mice. Further, EmrA1 contributes to oxidative stress resistance by affecting secretion of Francisella antioxidant enzymes SodB and KatG. This study exposes unique links between transporter activity and the antioxidant defence mechanisms of F. tularensis.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24397487      PMCID: PMC4097035          DOI: 10.1111/mmi.12509

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  48 in total

Review 1.  Mechanisms of pathogenesis: evasion of killing by polymorphonuclear leukocytes.

Authors:  Lee-Ann H Allen
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

2.  SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis.

Authors:  Miriam Braunstein; Benjamin J Espinosa; John Chan; John T Belisle; William R Jacobs
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

3.  Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma.

Authors:  Marina Santic; Maelle Molmeret; Yousef Abu Kwaik
Journal:  Cell Microbiol       Date:  2005-07       Impact factor: 3.715

4.  The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages.

Authors:  Helena Lindgren; Linda Stenman; Arne Tärnvik; Anders Sjöstedt
Journal:  Microbes Infect       Date:  2005-02-26       Impact factor: 2.700

5.  Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS.

Authors:  Thomas H Kawula; Joshua D Hall; James R Fuller; Robin R Craven
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

Review 6.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

7.  Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis.

Authors:  Helena Lindgren; Stephan Stenmark; Wangxue Chen; Arne Tärnvik; Anders Sjöstedt
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  The complete genome sequence of Francisella tularensis, the causative agent of tularemia.

Authors:  Pär Larsson; Petra C F Oyston; Patrick Chain; May C Chu; Melanie Duffield; Hans-Henrik Fuxelius; Emilio Garcia; Greger Hälltorp; Daniel Johansson; Karen E Isherwood; Peter D Karp; Eva Larsson; Ying Liu; Stephen Michell; Joann Prior; Richard Prior; Stephanie Malfatti; Anders Sjöstedt; Kerstin Svensson; Nick Thompson; Lisa Vergez; Jonathan K Wagg; Brendan W Wren; Luther E Lindler; Siv G E Andersson; Mats Forsman; Richard W Titball
Journal:  Nat Genet       Date:  2005-01-09       Impact factor: 38.330

9.  [Tularemia, a potential bioterrorism weapon].

Authors:  Philippe Bossi; François Bricaire
Journal:  Presse Med       Date:  2003-07-12       Impact factor: 1.228

10.  Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.

Authors:  Anju Singh; Tabassum Rahman; Meenakshi Malik; Anthony J Hickey; Cynthia A Leifer; Karsten R O Hazlett; Timothy J Sellati
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more
  18 in total

1.  Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence.

Authors:  Erik J Kopping; Christopher R Doyle; Vinaya Sampath; David G Thanassi
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  Roles of reactive oxygen species-degrading enzymes of Francisella tularensis SCHU S4.

Authors:  Johan Binesse; Helena Lindgren; Lena Lindgren; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2015-03-23       Impact factor: 3.441

3.  An AraC/XylS Family Transcriptional Regulator Modulates the Oxidative Stress Response of Francisella tularensis.

Authors:  Dina Marghani; Zhuo Ma; Anthony J Centone; Weihua Huang; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Bacteriol       Date:  2021-09-20       Impact factor: 3.490

4.  ThioredoxinA1 Controls the Oxidative Stress Response of Francisella tularensis Live Vaccine Strain (LVS).

Authors:  Zhuo Ma; Matthew Higgs; Maha Alqahtani; Chandra Shekhar Bakshi; Meenakshi Malik
Journal:  J Bacteriol       Date:  2022-04-27       Impact factor: 3.476

5.  Characterization of a Unique Outer Membrane Protein Required for Oxidative Stress Resistance and Virulence of Francisella tularensis.

Authors:  Maha Alqahtani; Zhuo Ma; Harshada Ketkar; Ragavan Varadharajan Suresh; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

6.  Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain.

Authors:  Zhuo Ma; Vincenzo C Russo; Seham M Rabadi; Yu Jen; Sally V Catlett; Chandra Shekhar Bakshi; Meenakshi Malik
Journal:  Mol Microbiol       Date:  2016-06-16       Impact factor: 3.501

7.  Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines.

Authors:  Seham M Rabadi; Belkys C Sanchez; Mrudula Varanat; Zhuo Ma; Sally V Catlett; Juan Andres Melendez; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

8.  Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Maha Alqahtani; Zhuo Ma; Kayla Fantone
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

9.  Preclinical testing of a vaccine candidate against tularemia.

Authors:  Ragavan Varadharajan Suresh; Zhuo Ma; Raju Sunagar; Vivek Bhatty; Sukalyani Banik; Sally V Catlett; Edmund J Gosselin; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

10.  Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida.

Authors:  Siva T Sarva; Robert H Waldo; Robert J Belland; Karl E Klose
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.